Skip to main content
Senti Biosciences Holdings, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
0.1572
+0.0166 (11.81%)
At close: Nov 11, 2026, 4:00 PM EST
0.1501
-0.0071 (-4.52%)
After-hours: Nov 11, 2026, 7:37 PM EST

SNTI Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.060.02-2.564.292.76
Revenue Growth
----40.25%55.23%387.81%
Gross Profit
-31.27-37.56-34.36-29.59-23.86-19.2
Operating Income
-53.32-58.3-54.28-64.44-62.08-40.45
Net Income
-49.56-61.44-55.31-71.06-58.21-55.32
Earnings Per Share
-1.71-2.73-12.03-16.01-22.29-189.95
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
6.6116.7448.6135.9799.7757.19
Total Debt
20.2328.8933.5437.6737.0922.73
Net Cash (Debt)
-13.62-12.1615.07-1.762.6834.46
Net Cash Growth
----81.89%108.68%
Net Cash Per Share
-0.47-0.543.28-0.3824.01118.33

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-38.05-43.44-41.4-52.4-34.9-34.64
Capital Expenditures
--0.2-0.03-12.04-41.37-5.54
Free Cash Flow
-38.05-43.64-41.42-64.43-76.27-40.18
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Margin
-96943.64%-265018.18%--2516.28%-1448.53%-1464.90%
Pretax Margin
-90116.36%-279263.64%--3256.77%-1158.77%-2003.59%
Profit Margin
-90116.36%-279263.64%--2774.62%-1358.14%-2003.59%
FCF Margin
-69183.64%-198363.64%--2515.93%-1779.51%-1455.20%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
89.751242.84-11.4814.43105.23